Nanjing Vazyme Biotech Co Ltd (688105) — Cash Flow Quality Index
Nanjing Vazyme Biotech Co Ltd (688105) has a Cash Flow Quality Index of 21.60x as of September 2025. Operating cash flow of CN¥75.30 Million exceeds net income of CN¥3.49 Million, indicating high earnings quality where cash backs reported profits. Also explore Nanjing Vazyme Biotech Co Ltd total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nanjing Vazyme Biotech Co Ltd Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Nanjing Vazyme Biotech Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688105 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Nanjing Vazyme Biotech Co Ltd (2017–2022)
Year-by-year earnings quality comparison for Nanjing Vazyme Biotech Co Ltd. For live market cap and the full company financial profile, see 688105 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.24x | CN¥735.17 Million | CN¥593.51 Million | ▲ +36.2% |
| 2021 | 0.91x | CN¥616.80 Million | CN¥678.29 Million | ▼ -7.0% |
| 2020 | 0.98x | CN¥803.55 Million | CN¥821.73 Million | ▲ +65.9% |
| 2019 | 0.59x | CN¥15.20 Million | CN¥25.79 Million | ▲ +115.3% |
| 2018 | -3.85x | CN¥-4.00 Million | CN¥1.04 Million | ▼ -263.5% |
| 2017 | -1.06x | CN¥-3.86 Million | CN¥3.64 Million | — |